Get Plus

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

Full coverage· Health· Updated

Israeli Study Links Weight-Loss Drugs to Lower Dementia Risk

An Israeli study of nearly 47,000 patients found that GLP-1 drugs, used for diabetes and obesity, were associated with a 14% lower risk of dementia compared to other diabetes treatments. The research, involving adults with type 2 diabetes and obesity, also noted stronger links in women and older adults.

2 newsrooms · 1 language · since

Sign in to baba News

Sign in to save this article and find it on your phone.

or use an email code

What happened

  1. 01Israeli study links GLP-1 drugs to 14% lower dementia risk in diabetes and obesity patients.
  2. 02Research involved nearly 47,000 Clalit Health Services patients with type 2 diabetes and obesity.
  3. 03Dementia risk reduction was more pronounced in women (22%) and older adults (18%).
  4. 04The benefit was specifically noted compared to older sulfonylurea diabetes drugs.
  5. 05Researchers caution that the observational study cannot prove causation and more trials are needed.

While promising, researchers emphasize that the observational study cannot prove causation and further clinical trials are needed. The findings suggest potential brain health benefits beyond weight and sugar control.

Translated and summarized by baba from Hamal, the latest report. Read Hamal’s original

The coverage

2 newsrooms on this story

Who covered it

  • LeftNone
  • Centre1
  • Right1
  • HarediNone
  • ArabNone

How it broke

See which of the 2 newsrooms broke it, and who waited